hexavalent group A streptococcal vaccine
a recombinant fusion peptide group A streptococcal vaccine containing N-terminal M protein fragments from serotypes 1, 3, 5, 6, 19, and 24; safe, well tolerated, and capable of inducing vigorous immune responses that are likely to confer protection against multiple group A streptococcal M types
Also Known As:
StreptAvax; hexavalent A streptococcal vaccine
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
Related Drugs and Biologics